Survey on the Pharmacy Follow-up of Alli Purchasers

N/ACompletedNCT01387243

GlaxoSmithKline80 enrolled

Overview

To assess the feasibility and acceptability of genuine pharmacy follow up of people wishing to lose weight.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Overweight

Interventions

OrlistatDRUG

60 mg

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Individuals who have been recognized as being eligible for treatment, who have agreed to pharmacy follow up, and have given their informed consent to take part in the survey.

Outcomes

Primary Outcomes

Change in Physical activity

Time frame: baseline to 1 year

Secondary Outcomes

Change in dietary behavior

Time frame: baseline to 1 year

Evaluation of care pathway (e.g., consultation with doctors, use of nutritional information)

Time frame: baseline to 1 year

Satisfaction with management (i.e., results on weight and treatment comfort)

Time frame: baseline to 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.